Head and Neck Cancers

Randomized Phase 2 Study of Nivolumab and Ipilimumab with or without Cabozantinib in Patients with Advanced Nasopharyngeal Carcinoma That Have Progressed After Platinum Treatment and Immunotherapy

Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events

Molecular Analysis for Combination Therapy Choice (ComboMATCH)

Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck

Immune Checkpoint Inhibitor Toxicity (I-CHECKIT): A Prospective Observational Study